AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glymiprl M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Pristine Pearl Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glymiprl M 1mg/500mg Tablet

Diabetic patients using the combined medication Glymiprl M (1mg/500mg) tablets, classified as an antidiabetic agent, manage type 2 diabetes mellitus. This dual-action formulation regulates blood glucose effectively in adults. Administer this medication with food, consistently at the same time daily for optimal results. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management, as directed by your healthcare provider. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; learn to recognize symptoms (sweating, dizziness, headache, tremors) and manage them promptly. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary foods, fruit juice). Alcohol consumption should be minimized due to its hypoglycemic effect. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and blood tests (complete blood count and liver function tests) are necessary.

Primary Ingredients of Glymiprl M 1mg/500mg Tablet

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Glymiprl M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glymiprl M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glymiprl M 1mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glymiprl M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glymiprl M 1mg/500mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glymiprl M 1mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Glymiprl M 1mg/500mg Tablet works:

Each Glymiprl M 1mg/500mg tablet combines glimepiride (a sulfonylurea) and metformin (a biguanide), two medications used to manage diabetes. Glimepiride stimulates pancreatic insulin release, thus reducing blood sugar. Metformin acts triply: by decreasing hepatic glucose production, impeding intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glymiprl M 1mg/500mg tablets with alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glymiprl M 1mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Lactation and Glymiprl M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Caution is advised when prescribing Glymiprl M 1mg/500mg Tablets to individuals with impaired renal function; dosage modification may be necessary. Patients with severe kidney disease should not use Glymiprl M 1mg/500mg Tablets. Physician consultation is recommended. Routine monitoring of kidney function is suggested during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glymiprl M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation should be at a low dose; however, Glymiprl M 1mg/500mg tablets are contraindicated in cases of severe liver disease.

What if you forget to take Glymiprl M 1mg/500mg Tablet :

Should you forget to take your Glymiprl M 1mg/500mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Glymiprl M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glymiprl M 1mg/500mg Tablet

Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glymiprl M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Glymiprl M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This treatment improves blood sugar control when combined with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glymiprl M 1mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glymiprl M 1mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Glymiprl M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glymiprl M 1mg/500mg tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glymiprl M 1mg/500mg Tabl...
41
MRP 50
18% off